Key facts
- This page summarizes Joseph Carleone's Form 4 filing for SENSIENT TECHNOLOGIES CORP (SXT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 01 Jul 2026, 17:58.
Joseph Carleone - 30 Jun 2026 Form 4 Insider Report for SENSIENT TECHNOLOGIES CORP (SXT)
- Reporting relationship
- Director
- Issuer ticker
- SXT
- Reported as of
- 30 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Jul 2026, 17:58:31 UTC
- Prior SEC filing
- 27 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ John J. Manning, Attorney-in-Fact for Dr. Carleone
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joseph Carleone filed Form 4 for SENSIENT TECHNOLOGIES CORP (SXT) on 01 Jul 2026.
Change
- Previous filing in this sequence was filed on 27 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001212515
Primary reporting owner
Carleone Joseph
- Relationship
- Director
- Address
- 777 EAST WISCONSIN AVENUE, MILWAUKEE
- Signature
- /s/ John J. Manning, Attorney-in-Fact for Dr. Carleone
- Signature date
- 01 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SXT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 23,735
- Date
- 30 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SXT
transaction
Derivative
Deferred Stock
Award
- Transaction value
- Shares
- +296
- Change %
- +1.2%
- Price
- $0.000000*
- Shares after
- 24,164
- Date
- 30 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 296
- Exercise price
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
Footnote F2
Deferred stock converts to common stock on a one-for-one basis.
Footnote F3
Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
Footnote F4
Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.